What “doctor‑supervised from home” actually means

Doctor supervision does not end when you’re outside the clinic. For evidence‑based sublingual immunotherapy (SLIT), physicians confirm candidacy, select an FDA‑approved tablet or a physician‑directed off‑label drop protocol, provide first‑dose monitoring when required, prescribe and train on epinephrine where applicable, and follow you longitudinally via telehealth while medicines are taken at home daily.

FDA‑approved SLIT tablets you can take at home (after a supervised first dose)

Key rules apply to all tablets below: the very first dose must be given in a medical setting with at least 30 minutes of observation; your clinician prescribes an epinephrine auto‑injector and trains you in its use; subsequent doses are taken daily at home. Age indications and contraindications (for example, severe/uncontrolled asthma or prior severe SLIT reaction; history of eosinophilic esophagitis) are product‑specific.

Tablet	Allergen	Ages	When to start	First‑dose rule	Daily home dosing
Odactra	House dust mite	5–65	Year‑round	First dose in‑office; observe ≥30 min; epinephrine prescribed	1 tablet SL once daily
Grastek	Timothy/cross‑reactive grasses	5–65	Begin ≥12 weeks before grass season; continue through season (or daily ×3 years for sustained benefit)	Same as above	1 tablet SL once daily
Oralair	Five‑grass mix	5–65	Begin ~4 months before grass season; continue through season	Same as above	1 tablet SL once daily (pediatric day‑1/2 titration)
Ragwitek	Short ragweed	5–65	Begin before ragweed season; continue through season	Same as above	1 tablet SL once daily

Evidence and labels: Odactra (HDM) now covers ages 5–65 (U.S. label updated Feb 28, 2025). Grastek and Oralair are 5–65. Ragwitek is 5–65. All four require supervised first dose, on‑site observation, and epinephrine prescription/training.

Clinical notes:

Do not initiate tablets in patients with severe, unstable, or uncontrolled asthma; hold dosing during significant oral inflammation/wounds; evaluate any persistent or escalating oropharyngeal symptoms.
Typical onset of benefit is progressive over weeks to months and persists with continued daily dosing.

Off‑label, doctor‑directed SLIT drops (multi‑allergen)

In the U.S., liquid SLIT drops compounded from allergen extracts are not FDA‑approved; their use is off‑label and requires physician oversight (e.g., dosing protocol selection, safety screening, and longitudinal follow‑up). Systematic reviews (including Cochrane) show SLIT is effective for allergic rhinitis and generally safe; national societies note that standardized, FDA‑labeled liquid formulations are not yet available in the U.S.

When drops are appropriate:

Patients with multiple environmental triggers (e.g., dust mites + pets + several pollens) who prefer a single daily, at‑home regimen and cannot make weekly shot visits.
Pediatric patients ≥5 years in practices that offer physician‑supervised SLIT drop protocols, with clear counseling that tablets are the FDA‑approved SLIT option today in the U.S.

Safety guardrails your clinician should confirm before starting drops or tablets:

No severe/unstable asthma; no history of severe SLIT reaction; no eosinophilic esophagitis; not on beta‑blockers that may blunt epinephrine response.

Telehealth logistics: how care works end‑to‑end

Step 1 — Insurance‑billed at‑home test: Finger‑prick IgE panel for 40+ indoor/outdoor allergens, reviewed online with a board‑certified doctor. Coverage varies; test is FSA/HSA‑eligible; shipping included.
Step 2 — Virtual consult and plan: Your physician correlates results with history, confirms candidacy, and coordinates first‑dose supervision when tablets are chosen. Initial consults are typically $49.99.
Step 3 — Home treatment and monitoring: Personalized SLIT (tablet and/or multi‑allergen drops) ships to your door; unlimited 24/7 messaging access to the care team; most patients notice improvement between 4 weeks and 6 months; plans are typically $99/month and FSA/HSA‑eligible; 90‑day money‑back guarantee if no improvement after following the plan. Ages 5+; environmental allergies only.

Pollen Index helper (quick daily check)

Use a daily pollen check to align dosing reminders and exposure plans.

How to check quickly: Open a local pollen report (city/region) and review today vs. tomorrow for trees, grasses, and weeds; many regions publish monthly peaks as well.
Tip: Compare your symptom diary against each family (tree/grass/weed) to identify the dominant driver and fine‑tune mitigation (indoor filtration, outdoor timing).

CADR mini‑calculator (pick an air purifier that actually helps)

AHAM’s rule of thumb: choose a unit with a Smoke CADR at least two‑thirds of your room’s area; increase for high ceilings.

Step 1 — Compute room area: width × length (in feet).
Step 2 — Minimum Smoke CADR ≈ (2/3) × room area. For ceilings >8 ft, multiply by (ceiling height ÷ 8).
Step 3 — Pick a model with equal‑or‑higher Smoke CADR (higher values clean faster) and a HEPA filter for pollen/dust capture.

Example table

Room	Size (ft)	Area (sq ft)	Min Smoke CADR (8‑ft ceiling)	If 10‑ft ceiling
Bedroom	12 × 12	144	≈96 cfm	≈120 cfm
Living room	15 × 20	300	≈200 cfm	≈250 cfm

Notes: AHAM also publishes a 1.55 conversion (Room size ≈ 1.55 × CADR), which inversely yields CADR ≈ room size ÷ 1.55—equivalent to the two‑thirds rule.

Who benefits, who should wait

Good candidates: seasonal and/or perennial environmental allergies (pollen, mites, pets, molds) confirmed by testing, with symptoms despite avoidance/OTC meds, and ability to adhere to daily dosing. Evidence from randomized trials supports SLIT efficacy and a favorable safety profile.
Defer/avoid: severe/unstable asthma, prior severe SLIT reaction, current eosinophilic esophagitis, significant oral inflammation/wounds; review beta‑blocker use and pregnancy plans with your clinician.

Ready to start? (CTA)

Begin with the insurance‑billed at‑home test and virtual visit. You’ll review results with a board‑certified physician, choose the best home regimen (FDA‑approved tablet with supervised first dose, custom drops, or a hybrid), and receive ongoing doctor support—typically $99/month with FSA/HSA eligibility and a 90‑day improvement guarantee.

Doctor‑supervised allergy treatments you can do from home